PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
17-Oct-2024 CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance AccessWire
17-Oct-2024 Biodexa's MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer AccessWire
17-Oct-2024 Moderna to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 AccessWire
17-Oct-2024 Justera Health Completes Acquisition of Popular Cannabis Brand, Port North AccessWire
17-Oct-2024 Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica AccessWire
17-Oct-2024 Angle PLC Announces Publication Demonstrates CTC Profiling Potential AccessWire
16-Oct-2024 Lexaria Announces Closing of $5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules AccessWire
16-Oct-2024 Parcel Health Introduces Tully Tube: The World's First Paper Prescription Bottle AccessWire
16-Oct-2024 How to Care for New Dental Bridges AccessWire
16-Oct-2024 The Vets and BetterVet Announce Merger, Ushering in a New Era of Pet Healthcare AccessWire
16-Oct-2024 AGFA HealthCare Set to Unveil 'Next-Generation' Enterprise Imaging with Groundbreaking Innovations at RSNA 2024 AccessWire
16-Oct-2024 New Study Shows Waymark Achieved a 22.9% Reduction in All-Cause ED and Hospital Visits in 2023 AccessWire
16-Oct-2024 Champions Oncology Announces Agreement with Weill Cornell Medicine AccessWire
16-Oct-2024 PathPresenter and Paige Announce Partnership to Accelerate Adoption of Image Management and Artificial Intelligence Digital Pathology Workflows AccessWire
16-Oct-2024 90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations AccessWire
16-Oct-2024 ful. CashPay Welcomes BeneStream to Its Healthcare Ecosystem, Providing Medicaid, Medicare, CHIP, and ACA Assistance to Essential Workers AccessWire
16-Oct-2024 Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells AccessWire
16-Oct-2024 Confidential Home Detox for Drugs and Alcohol Now Serving Los Angeles AccessWire
16-Oct-2024 Jaguar Health Launches FDA-Approved Oral Mucositis Prescription Product Gelclair in the U.S. AccessWire
16-Oct-2024 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform AccessWire